The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Abstract
Fibroblast growth factor 21 (FGF21) is a metabolic regulator that provides efficient and durable glycemic and lipid control in various animal models. However, its potential to treat obesity, a major health concern affecting over 30% of the population, has not been fully explored. Here we report that systemic administration of FGF21 for 2 wk in diet-induced obese and ob/ob mice lowered their mean body weight by 20% predominantly via a reduction in adiposity. Although no decrease in total caloric intake or effect on physical activity was observed, FGF21-treated animals exhibited increased energy expenditure, fat utilization, and lipid excretion, reduced hepatosteatosis, and ameliorated glycemia. Transcriptional and blood cytokine profiling studies revealed effects consistent with the ability of FGF21 to ameliorate insulin and leptin resistance, enhance fat oxidation and suppress de novo lipogenesis in liver as well as to activate futile cycling in adipose. Overall, these data suggest that FGF21 exhibits the therapeutic characteristics necessary for an effective treatment of obesity and fatty liver disease and provides novel insights into the metabolic determinants of these activities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“prolonged administration of FGF21 or FGF21 analogues has important metabolic effects, including a marked decrease in body weight in rodents and non-human primates, and more modest effects on body weight in humans3,40,58,77,78.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [77]
In the citing paper
“Pharmacological administration of FGF21 to obese rodents reverses diabetes and obesity through increasing energy expenditure77,78.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [77]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [131]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [131]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [131]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [131]
In the citing paper
“A myriad of studies ensued demonstrating that administering FGF21 to obese or diabetic rodents and primates markedly reduced body weight and significantly improved carbohydrate and lipid homeostasis (21, 64, 65, 141).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [21]
In the citing paper
“When administered to diabetic and obese animal models, FGF21 provides multiple metabolic benefits and has been shown to decrease blood glucose levels and body weight, improve insulin and leptin sensitivity, improve plasma lipid profiles, and decrease hepatic steatosis (21, 64, 141, 142).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [21]
In the citing paper
“Importantly, in animal models FGF21 treatment not only prevents (64) but also reverses diabetes and obesity (21, 141).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [21]
In the citing paper
“Since FGF21 administration increases energy expenditure and the browning of adipose tissues in vivo (21, 64, 141), it was hypothesized that FGF21 regulates adaptive thermogenesis in response to cold.”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [21]
In the citing paper
“It is clear that FGF21 treatment elicits significant metabolic changes in many tissues, including the liver and adipose tissues (21, 141).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [21]
In the citing paper
“FGF21’s ability to reduce body weight, glucose levels, and lipid concentrations in models of obesity generated substantial initial interest”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [116]
Citations
Cites
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Self-citationCellular signaling by fibroblast growth factor receptors
Eswarakumar, V. P., Lax, I., & Schlessinger, J. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.001 · Cited by 1,923
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123
Handschin, C., & Spiegelman, B. M. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0037 · Cited by 1,090
New drug targets for type 2 diabetes and the metabolic syndrome
Moller, D. E. (2001) · Nature · doi:10.1038/414821a · Cited by 1,012
Self-citationIdentification of a novel FGF, FGF-21, preferentially expressed in the liver
Nishimura, T., Nakatake, Y., Konishi, M., & Itoh, N. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00067-1 · Cited by 847
Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss
Cohen, P., Miyazaki, M., Socci, N. D., Hagge-Greenberg, A., Liedtke, W., Soukas, A. A., Sharma, R., Hudgins, L. C., Ntambi, J. M., & Friedman, J. M. (2002) · Science · doi:10.1126/science.1071527 · Cited by 826
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 995
Li, S., Wang, N., Guo, X., Li, J., Zhang, T., Ren, G., & Li, D. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.078 · Cited by 25
Estrogen-Wnt signaling cascade regulates expression of hepatic fibroblast growth factor 21
Badakhshi, Y., Shao, W., Liu, D., Tian, L., Pang, J., Gu, J., Hu, J., & Jin, T. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00638.2020 · Cited by 23
Xiang, C., Zhang, Y., Chen, Q., Sun, A., Peng, Y., Zhang, G., Zhou, D., Xie, Y., Hou, X., Zheng, F., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16698 · Cited by 23
A pyrexic effect of FGF21 independent of energy expenditure and UCP1
Zouhar, P., Janovská, P., Stanić, S., Bardová, K., Funda, J., Haberlova, B., Andersen, B., Rossmeisl, M., Cannon, B., Kopecký, J., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101324 · Cited by 24
Metabolic Effects of FGF-21: Thermoregulation and Beyond
Ni, B., Farrar, J. S., Vaitkus, J. A., & Celi, F. S. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00148 · Cited by 23
Adipose tissue autophagy and homeostasis in alcohol-induced liver injury
Li, Y., & Ding, W. (2017) · Liver Research · doi:10.1016/j.livres.2017.03.004 · Cited by 23
Hansen, A. M. K., Vienberg, S. G., Lykkegaard, K., Zhao, X., Tingqing, G., Han, D., Zhang, X., Thøgersen, H., Sass‐Ørum, K., Tagmose, T. M., et al. (2018) · Biochemical Journal · doi:10.1042/bcj20180555 · Cited by 23
The autocrine role of FGF21 in cultured adipocytes
Justesen, S., Haugegaard, K. V., Hansen, J. B., Hansen, H. S., & Andersen, B. (2020) · Biochemical Journal · doi:10.1042/bcj20200220 · Cited by 25
Cui, X., Sun, Q., & Wang, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1510322 · Cited by 24
Long-Term Dietary Taurine Lowers Plasma Levels of Cholesterol and Bile Acids
Tagawa, R., Kobayashi, M., Sakurai, M., Yoshida, M., Kaneko, H., Mizunoe, Y., Nozaki, Y., Okita, N., Sudo, Y., & Higami, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031793 · Cited by 22
Alpha lipoic acid induces hepatic fibroblast growth factor 21 expression via up-regulation of CREBH
Bae, K.-H., Min, A.-K., Kim, J., Lee, I., & Park, K. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.147 · Cited by 22
Xu, Q., Lin, S., Li, Q., Lin, Y., Xiong, Y., Zhu, J., & Wang, Y. (2019) · Animal Biotechnology · doi:10.1080/10495398.2019.1691010 · Cited by 22
Jacobsen, J. M., Petersen, N., Torz, L., Gerstenberg, M. K., Pedersen, K., Østergaard, S., Wulff, B. S., Andersen, B., Raun, K., Christoffersen, B. Ø., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114501 · Cited by 22
MECHANISMS IN ENDOCRINOLOGY: Brown adipose tissue in humans: regulation and metabolic significance
Thuzar, M., & Ho, K. K. Y. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1217 · Cited by 22
Flis, M., Kortas, J. A., Żychowska, M., Antosiewicz, J., Żuczek, K., Perego, S., Lombardi, G., & Ziemann, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-86430-9 · Cited by 21
Leptin, Acting at Central Level, Increases FGF21 Expression in White Adipose Tissue via PPARβ/δ
Mazuecos, L., Pintado, C., Rubio, B., Guisantes-Batán, E., Andrés, A., & Gallardo, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094624 · Cited by 21
En, M., Kazantseva, A. Y., Dubinina, A., Denisova, E. I., Jakovleva, T., Balybina, N., Bgatova, N. P., Baranov, K. O., & Бажан, Н. М. (2021) · Cells · doi:10.3390/cells10123440 · Cited by 20
Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities
Li, J., Duan, H., Liu, Y., Wang, L., & Zhou, X. W. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071445 · Cited by 23
Nielsen, M. H., Gillum, M. P., Vrang, N., Jelsing, J., Hansen, H. H., Feigh, M., & Oró, D. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00157.2022 · Cited by 20
Goutam, R. S., Kumar, V., Lee, U., & Kim, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087556 · Cited by 20
Zhang, M., Jiang, X., Su, Z., Lin, J., Xiang, Q., Yang, Z., Huang, Y., & Li, X. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3427-8 · Cited by 21
Influence of growth hormone on circulating fibroblast growth factor 21 levels in humans
Lundberg, J. O., Höybye, C., Krusenstjerna-Hafstrøm, T., Bina, H. A., Kharitonenkov, A., Angelin, B., & Rudling, M. J. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12112 · Cited by 21
Self-citationKim, G.-Y., Lee, Y., Cho, J., Pan, C., Jun, H. S., Springer, D., Mansfield, B. C., & CHOU, J. Y. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv230 · Cited by 21
Variant Near FGF5 Has Stronger Effects on Blood Pressure in Chinese With a Higher Body Mass Index
Li, J., Shi, J., Huang, W., Sun, J., Wu, Y., Duan, Q., Luo, J., Lange, L. A., Gordon‐Larsen, P., Zheng, S. L., et al. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpu263 · Cited by 21
Berberine-induced activation of AMPK increases hepatic FGF21 expression via NUR77
Zhou, F., Bai, M., Zhang, Y., Zhu, Q., Zhang, L., Zhang, Q., Wang, S., Zhu, K., Liu, Y., Wang, X., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.070 · Cited by 22
Lewis, J. E., Monnier, C., Marshall, H. J., Fowler, M. J., Green, R., Cooper, S., Chiotellis, A., Luckett, J., Perkins, A. C., Coşkun, T., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.009 · Cited by 25
Ma, Q., Hu, L., Zhu, J., Chen, J., Wang, Z., Yue, Z., Qiu, M., & Shan, A. (2020) · ACS Omega · doi:10.1021/acsomega.0c03707 · Cited by 21
Association of fibroblast growth factor 21 with alcohol consumption and alcohol liver cirrhosis
Wagner‐Skacel, J., Horvath, A., Grande, P., Wenninger, J., Matzer, F., Fazekas, C., Mörkl, S., Meinitzer, A., & Stadlbauer, V. (2020) · Neuropsychiatrie · doi:10.1007/s40211-020-00380-8 · Cited by 21
Wu, X., & Li, Y. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0887-1_13 · Cited by 21
Kugler, B. A., Lourie, J., BERGER, N. J. A., Lin, N., Nguyen, P., DosSantos, E., Ali, A. S., Sesay, A., Rosen, H. G., KALEMBA, B. L., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101802 · Cited by 21
A Novel Approach to Improve the Function of FGF21
Smith, R. W., Duguay, A. N., Weiszmann, J., Stanislaus, S., Belouski, E., Cai, L., Yie, J., Xu, J., Gupte, J., Wu, X., et al. (2013) · BioDrugs · doi:10.1007/s40259-013-0013-x · Cited by 20
Xu, C., Xu, Q., Chen, Y., Yang, W., Xia, C., Yu, H., Zhu, K., Shen, T., & Zhang, Z. (2015) · BMC Veterinary Research · doi:10.1186/s12917-015-0585-4 · Cited by 20
Self-citationGuo, J., Chen, H.-H., Lee, W., Chen, S., Lee, S., & Chen, C. (2022) · Nutrients · doi:10.3390/nu14030645 · Cited by 21
Lee, S. A., Jeong, E., Kim, E. H., Shin, M., Hwang, J. Y., Koh, E. H., Lee, W. J., Park, J., & Kim, M. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.1.29 · Cited by 19
Guo, Q., Xu, L., Liu, J., Li, H., Sun, H., Wu, S., & Zhou, B. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216677354 · Cited by 20
Ippagunta, S. M., Kharitonenkov, A., Adams, A. C., & Hillgartner, F. B. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy022 · Cited by 21
Self-citationMetabolic Factors Determining the Susceptibility to Weight Gain: Current Evidence
Hollstein, T., & Piaggi, P. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00371-4 · Cited by 24
Current understanding and controversies on the clinical implications of fibroblast growth factor 21
Badakhshi, Y., & Jin, T. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1864278 · Cited by 20
Free Fatty Acids Impair FGF21 Action in HepG2 Cells
Asrih, M., Montessuit, C., Philippé, J., & Jornayvaz, F. R. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000438540 · Cited by 20
Beneficial Effects of Low-Grade Mitochondrial Stress on Metabolic Diseases and Aging
Min, S. H., Kang, G. M., Park, J.-W., & Kim, M. (2024) · Yonsei Medical Journal · doi:10.3349/ymj.2023.0131 · Cited by 20
Cao, Y., Araki, M., Nakagawa, Y., Deisen, L., Lundsgaard, A., Kanta, J. M., Holm, S. K., Johann, K., Jacobsen, J. C., Jähnert, M., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101991 · Cited by 25
Ye, X., Qi, J., Ren, G., Xu, P., Wu, Y., Zhu, S., Yu, D., Li, S., Wu, Q., Muhi, R. L., et al. (2015) · Endocrine · doi:10.1007/s12020-014-0503-8 · Cited by 19
Idrees, M., Kumar, V., Khan, A. M., Joo, M., Lee, K.-W., Sohn, S. H., & Kong, I. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111756 · Cited by 19
Spermidine activates adipose tissue thermogenesis through autophagy and fibroblast growth factor 21
Ni, Y., Zheng, L., Zhang, L., Li, J., Pan, Y., Du, H., Wang, Z., & Fu, Z. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109569 · Cited by 18
Sui, Y., Liu, Q., Xu, C., Ganesan, K., Ye, Z., Li, Y., Wu, J., Du, B., Gao, F., Song, C., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-023-06386-8 · Cited by 19
Zibar, K., Blaslov, K., Bulum, T., Čuča, J. K., & Duvnjak, L. S. (2014) · Endocrine · doi:10.1007/s12020-014-0413-9 · Cited by 19
Akyıldız, Z. İ., Polat, S., Yürekli, B. Ş., Kocabaş, G. Ü., Tülüce, K., Tülüce, S. Y., Kocabaş, U., Bozkaya, G., Yüksel, A., & Nazlı, C. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0185-3 · Cited by 19
Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway
Yu, D., Ye, X., Wu, Q., Li, S., Yang, Y., He, J., Liu, Y., Zhang, X., Yuan, Q., Liu, M., et al. (2015) · Endocrine · doi:10.1007/s12020-015-0801-9 · Cited by 19
Liu, X., Wang, Y., Zhao, S., & Li, X. (2017) · BioMed Research International · doi:10.1155/2017/1648715 · Cited by 19
FGF21 decreases food intake and body weight in obese Göttingen minipigs
Christoffersen, B. Ø., Straarup, E. M., Lykkegaard, K., Fels, J. J., Sass‐Ørum, K., Zhang, X., Raun, K., & Andersen, B. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13560 · Cited by 19
SCO‐792, an enteropeptidase inhibitor, improves disease status of diabetes and obesity in mice
Yashiro, H., Hamagami, K., Hiyoshi, H., Sugama, J., Tsuchimori, K., Yamaguchi, F., Moritoh, Y., Sasaki, M., Maekawa, T., Yamada, Y., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13799 · Cited by 20
Hung, Y.-H., Kanke, M., Kurtz, C. L., Cubitt, R. L., Bunaciu, R. P., Zhou, L., White, P. J., Vickers, K. C., Hussain, M. M., Li, X., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01367 · Cited by 19
Donate-Correa, J., Martín-Núñez, E., González-Luis, A., Ferri, C., Luis-Rodríguez, D., TAGUA, V. G., Mora-Fernández, C., & Navarro-González, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122583 · Cited by 17
Diabetes Mellitus: New Challenges and Innovative Therapies
Sena, C. M., Bento, C. F., Pereira, P., Marquês, F., & Seiça, R. M. F. (2013) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-5971-8_3 · Cited by 20
Transcriptional control and hormonal response of thermogenic fat
Emont, M. P., Yu, H. M., & Wu, J. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0026 · Cited by 19
The FGFR D3 Domain Determines Receptor Selectivity For Fibroblast Growth Factor 21
Gupte, J., Li, Y., Wu, X., Weiszmann, J., Hecht, R. I., Lemon, B. D., Lindberg, R. A., Wang, Z., & Li, Y. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.003 · Cited by 18
Jin, T. (2018) · Obesity Medicine · doi:10.1016/j.obmed.2018.11.002 · Cited by 19
Andersen, B., Omar, B. A., Rakipovski, G., Raun, K., & Åhrén, B. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.003 · Cited by 18
Fan, H. J., Sun, X., Zhang, H., Liu, J., Zhang, P., Xu, Y., Pan, Q., & Wang, G. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0261 · Cited by 18
Cardiac myocyte KLF5 regulates body weight via alteration of cardiac FGF21
Pol, C. J., Pollak, N. M., Jurczak, M. J., Zacharia, E. M., Karagiannides, I., Kyriazis, I. D., Ntziachristos, P., Scerbo, D. A., Brown, B. R., Aifantis, I., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.04.010 · Cited by 18
Weng, W., Ge, T., Wang, Y., He, L., Liu, T., Wang, W., Zheng, Z., Yu, L., Zhang, C., & Lu, X. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0089 · Cited by 18
Jung, Y. S., Lee, J.-M., Kim, D., Lee, Y. S., Kim, K.-S., Kim, Y., Kim, J., Lee, M., Lee, I., Kim, S. H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159425 · Cited by 18
Dual effects of fibroblast growth factor 21 on hepatic energy metabolism
Samms, R. J., Murphy, M., Fowler, M. J., Cooper, S., Emmerson, P. J., Coşkun, T., Adams, A. C., Kharitonenkov, A., Ebling, F. J. P., & Tsintzas, K. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0334 · Cited by 17
Self-citationMetabolic remodeling induced by mitokines in heart failure
Duan, J., Chen, Z., Wu, Y., Zhu, B., Yang, L., & Yang, C. (2019) · Aging · doi:10.18632/aging.102247 · Cited by 17
Threonine supplementation prevents the development of fat deposition in mice fed a high-fat diet
Chen, J., Qian, D., Wang, Z., Sun, Y., Sun, B., Zhou, X., Hu, L., Shan, A., & Ma, Q. (2022) · Food & Function · doi:10.1039/d2fo01201d · Cited by 17
Weber, A. J., Medak, K. D., Townsend, L. K., & Wright, D. C. (2022) · The Journal of Physiology · doi:10.1113/jp283469 · Cited by 18
Mirrazavi, Z. S., & Behrouz, V. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.01.005 · Cited by 20
Weighing in on the role of brown adipose tissue for treatment of obesity
Prapaharan, B., Lea, M. B. S., & Beaudry, J. L. (2024) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.3389/jpps.2024.13157 · Cited by 19
Adipocytokines, gut hormones and growth factors in anorexia nervosa
Kowalska, I., Karczewska‐Kupczewska, M., & Strączkowski, M. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.06.007 · Cited by 18
Thompson, A. C. S., Bruss, M. D., Nag, N., Kharitonenkov, A., Adams, A. C., & Hellerstein, M. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111418 · Cited by 17
Self-citationFibroblast Growth Factor 21-Null Mice Do Not Exhibit an Impaired Response to Fasting
Antonellis, P. J., Hayes, M. P., & Adams, A. C. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00077 · Cited by 17
Nutrigenomic Functions of PPARs in Obesogenic Environments
Chung, S., Kim, Y. J., Yang, S. J., Lee, Y., & Lee, M. (2016) · PPAR Research · doi:10.1155/2016/4794576 · Cited by 19
Fletcher, J. A., Linden, M. A., Sheldon, R. D., Meers, G. M.-E., Morris, E. M., Butterfield, A. M., Perfield, J. W., Rector, R. S., & Thyfault, J. P. (2017) · Experimental Physiology · doi:10.1113/ep086629 · Cited by 17
Sandoval, V., Rodríguez‐Rodríguez, R., Martínez‐Garza, Ú., Rosell‐Cardona, C., Lamuela-Raventós, R. M., Marrero, P. F., Haro, D., & Relat, J. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700606 · Cited by 17
Delaye, J.-B., Lanznaster, D., Veyrat‐Durebex, C., Fontaine, A., Bacle, G., Lefèvre, A., Hergesheimer, R., Lecron, J., Vourc’h, P., Andres, C. R., et al. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00933-3 · Cited by 17
Fibroblast growth factor 21 in dairy cows: current knowledge and potential relevance
Eder, K., Geßner, D. K., & Ringseis, R. (2021) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-021-00621-y · Cited by 18
Zhang, M., Liu, Y., Xiong, Z.-Y., Deng, Z., Song, H., & An, Z. (2013) · PubMed · Cited by 17
Phelps, M., Stuelsatz, P., & Yablonka‐Reuveni, Z. (2016) · FEBS Journal · doi:10.1111/febs.13682 · Cited by 17
Hu, W., He, J., Fu, W., Wang, C., Yue, H., Gu, J., Zhang, H., & Zhang, Z. (2018) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2018.08.005 · Cited by 17
Zarei, M., Pujol, E., Quesada‐López, T., Villarroya, F., Barroso, E., Vázquez, S., Pizarro‐Delgado, J., Palomer, X., & Vázquez‐Carrera, M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14678 · Cited by 17
Seo, Y., Lee, K., Chei, S., Jeon, Y., & Lee, B.-Y. (2019) · Marine Drugs · doi:10.3390/md17070407 · Cited by 17
Alizadeh‐Fanalou, S., Babaei, M., Hosseini, A., Azadi, N. A., Nazarizadeh, A., Shojaii, A., Borji, M., Malekinejad, H., & Bahreini, E. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112331 · Cited by 17
Soundarrajan, M., Deng, J., Kwasny, M., Rubert, N. C., Nelson, P. C., Abou-el-Seoud, D., Landsberg, L., & Neff, L. M. (2020) · Adipocyte · doi:10.1080/21623945.2020.1724740 · Cited by 20
Nonogaki, K., & Kaji, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-72975-8 · Cited by 16
Antonellis, P. J., Kharitonenkov, A., & Adams, A. C. (2014) · Journal of Animal Science · doi:10.2527/jas.2013-7076 · Cited by 15
Self-citationReduction of Plasma BCAAs following Roux-en-Y Gastric Bypass Surgery Is Primarily Mediated by FGF21
Shah, H., Kramer, A., Mullins, C. A., Mattern, M., Gannaban, R. B., Townsend, R. L., Campagna, S. R., Morrison, C. D., Berthoud, H., & Shin, A. C. (2023) · Nutrients · doi:10.3390/nu15071713 · Cited by 17
Fibroblast Growth Factors in Cardiovascular Disease
Morita, H., & Hoshiga, M. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv22025 · Cited by 16
Jiang, S., Zhang, R., Li, H., Fang, Q., Jiang, F., Hou, X., Hu, C., & Jia, W. (2014) · Lifestyle Genomics · doi:10.1159/000367943 · Cited by 16
Self-citationSearching for ways to switch on brown fat: are we getting warmer?
Whittle, A. J. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0080 · Cited by 16
Mayer, A. L., Zhang, Y., Feng, E. H., Higgins, C. B., Adenekan, O., Pietka, T., Beatty, W. L., & DeBosch, B. J. (2018) · Endocrinology · doi:10.1210/en.2017-03150 · Cited by 16
Epperlein, S., Gebhardt, C., Rohde, K., Chakaroun, R., Patt, M., Schamarek, I., Kralisch, S., Heiker, J. T., Scholz, M. R., Stümvoll, M., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9040345 · Cited by 16
Effects of Mitochondrial Dynamics in the Pathophysiology of Obesity
Wang, J., Lin, X., Zhao, N., Dong, G., Wu, W., Huang, K., & Fu, J. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2703107 · Cited by 16
Garcia‐Caraballo, S., Comhair, T. M., Dejong, C. H. C., Lamers, W. H., & Köhler, E. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.04.022 · Cited by 16
Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs
d’Angelo, M., Castelli, V., Tupone, M. G., Catanesi, M., Antonosante, A., Dominguez-Benot, R., Ippoliti, R., Cimini, A., & Benedetti, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215422 · Cited by 17
Aja, P. M., Awoke, J. N., Agu, P. C., Adegboyega, A. E., Ezeh, E. M., Igwenyi, I. O., Orji, O. U., Ani, O. G., Ale, B. A., & Ibiam, U. A. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-022-00370-z · Cited by 15
Impact of metabolic stress induced by diets, aging and fasting on tissue oxygen consumption
Mackert, O., Wirth, E. K., Sun, R., Winkler, J. L., Liu, A., Renko, K., Kunz, S., Spranger, J., & Brachs, S. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101563 · Cited by 17
Age-dependent sex difference of non-alcoholic fatty liver disease in TSOD and db/db mice
Dungubat, E., Kusano, H., Mori, I., Tawara, H., Sutoh, M., Ohkura, N., Takanashi, M., Kuroda, M., Harada, N., Udo, E., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278580 · Cited by 15
Hepatokine Profile in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study
Giannouli, A., Stefanaki, C., Kouskoutis, C., Konidari, M., Mani, I., Konidari, K., Markantonis, S. L., Mantzou, A., Dourakis, S. P., Deligeoroglou, E., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175744 · Cited by 15
Dewal, R. S., Yang, F. T., Baer, L. A., Vidal, P., Hernández‐Saavedra, D., Seculov, N. P., Ghosh, A., Noé, F., Togliatti, O., Hughes, L., et al. (2024) · iScience · doi:10.1016/j.isci.2024.108927 · Cited by 16
Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms
Richter, M. M., Kemp, I. M., Heebøll, S., Winther‐Sørensen, M., Kjeldsen, S. A. S., Jensen, N. J., Nybing, J. D., Linden, F. H., Høgh‐Schmidt, E., Boesen, M., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155915 · Cited by 15
Metadata
- Authors
- Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A.
- Affiliations
- Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana 46285
- Eli Lilly (United States) (US)
- Corresponding author
- Kharitonenkov, Alexei
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2008-08-07
- Volume
- 149
- Issue
- 12
- Pages
- 6018-6027
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2114650931
- Cited by
- 1,031
- References
- 26
- Citations by year
- 2026: 17 · 2025: 34 · 2024: 58 · 2023: 63 · 2022: 57 · 2021: 72 · 2020: 67 · 2019: 76 · 2018: 72 · 2017: 64 · 2016: 78 · 2015: 85 · 2014: 71 · 2013: 62 · 2012: 61
- FWCI
- 12.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- FGF21, obesity, diet-induced obesity, ob/ob mice, energy expenditure, fat oxidation, de novo lipogenesis, hepatic steatosis, insulin resistance, leptin resistance, glycemia, lipid excretion, adipose tissue, metabolic therapy
- MeSH terms
- Animals, Body Weight, Energy Intake, Dietary Fats, Energy Metabolism, Fibroblast Growth Factors, Insulin, Insulin Resistance, Male, Mice, Inbred C57BL, Motor Activity, Obesity, Leptin, Adiposity, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
